Lenaers Guy, Reynier Pascal, Elachouri Ghizlane, Soukkarieh Chadi, Olichon Aurélien, Belenguer Pascale, Baricault Laurent, Ducommun Bernard, Hamel Christian, Delettre Cécile
INSERM U-583, Institut des Neurosciences de Montpellier, Université de Montpellier I et II, Montpellier, France.
Int J Biochem Cell Biol. 2009 Oct;41(10):1866-74. doi: 10.1016/j.biocel.2009.04.013. Epub 2009 Apr 21.
OPA1 is the major gene responsible for Dominant Optic Atrophy (DOA), a blinding disease that affects specifically the retinal ganglion cells (RGCs), which function consists in connecting the neuro-retina to the brain. OPA1 encodes an intra-mitochondrial dynamin, involved in inner membrane structures and ubiquitously expressed, raising the critical question of the origin of the disease pathophysiology. Here, we review the fundamental knowledge on OPA1 functions and regulations, highlighting their involvements in mitochondrial respiration, membrane dynamic and apoptosis. In light of these functions, we then describe the remarkable RGC mitochondrial network physiology and analyse data collected from animal models expressing OPA1 mutations. If, to date RGC mitochondria does not present any peculiarity at the molecular level, they represent possible targets of numerous assaults, like light, pressure, oxidative stress and energetic impairment, which jeopardize their function and survival, as observed in OPA1 mouse models. Although fascinating fields of investigation are still to be addressed on OPA1 functions and on DOA pathophysiology, we have reached a conspicuous state of knowledge with pertinent cell and animal models, from which therapeutic trials can be initiated and deeply evaluated.
OPA1是导致显性遗传性视神经萎缩(DOA)的主要基因,DOA是一种致盲疾病,专门影响视网膜神经节细胞(RGCs),其功能是将神经视网膜与大脑相连。OPA1编码一种线粒体内的发动蛋白,参与内膜结构,且广泛表达,这就引发了疾病病理生理学起源的关键问题。在此,我们回顾关于OPA1功能和调控的基础知识,强调它们在线粒体呼吸、膜动态变化和细胞凋亡中的作用。鉴于这些功能,我们接着描述RGC线粒体网络的显著生理学特征,并分析从表达OPA1突变的动物模型收集的数据。如果说,迄今为止RGC线粒体在分子水平上没有表现出任何特殊性,那么它们却是众多攻击的可能靶点,如光照、压力、氧化应激和能量损伤,这些会危及它们的功能和存活,正如在OPA1小鼠模型中所观察到的那样。尽管关于OPA1功能和DOA病理生理学仍有引人入胜的研究领域有待探索,但我们利用相关的细胞和动物模型已经达到了显著的知识状态,从中可以启动并深入评估治疗试验。